Effects of continuous long-term testosterone therapy (TTh) on anthropometric, endocrine and metabolic parameters for up to 10 years in 115 hypogonadal elderly men: real-life experience from an observational registry study

A. A. Yassin; J. Nettleship; Y. Almehmadi; M. Salman; F. Saad

doi:10.1111/and.12514

Effects of continuous long-term testosterone therapy (TTh) on anthropometric, endocrine and metabolic parameters for up to 10 years in 115 hypogonadal elderly men: real-life experience from an observational registry study

Andrologia ◽

10.1111/and.12514 ◽

2016 ◽

Vol 48 (7) ◽

pp. 793-799 ◽

Cited By ~ 20

Author(s):

A. A. Yassin ◽

J. Nettleship ◽

Y. Almehmadi ◽

M. Salman ◽

F. Saad

Keyword(s):

Life Experience ◽

Real Life ◽

Metabolic Parameters ◽

Registry Study ◽

Elderly Men ◽

Testosterone Therapy

Download Full-text

MP27-03 EFFECTS OF CONTINUOUS LONG-TERM TESTOSTERONE REPLACEMENT THERAPY (TRT) UP TO 11 YEARS IN 115 HYPOGONADAL ELDERLY MEN ON ANTHROPOMETRIC, ENDOCRINE AND METABOLIC PARAMETERS: REAL-LIFE EXPERIENCE FROM AN OBSERVATIONAL REGISTRY STUDY

The Journal of Urology ◽

10.1016/j.juro.2015.02.1165 ◽

2015 ◽

Vol 193 (4S) ◽

Author(s):

Aksam Yassin ◽

Yousef Al Mehmadi ◽

Dany-Jan Yassin ◽

Gheorghe Doros ◽

Abdul Traish

Keyword(s):

Replacement Therapy ◽

Life Experience ◽

Real Life ◽

Metabolic Parameters ◽

Testosterone Replacement ◽

Testosterone Replacement Therapy ◽

Registry Study ◽

Elderly Men

Download Full-text

1137-P: Remission of Type 2 Diabetes (T2DM) in 33.6% (51 of 152) Hypogonadal Men Receiving Long-Term Testosterone Therapy for Up to 12 Years in a Real-Life Registry Study

Diabetes ◽

10.2337/db19-1137-p ◽

2019 ◽

Vol 68 (Supplement 1) ◽

pp. 1137-P

Author(s):

KARIM S. HAIDER ◽

AHMAD HAIDER ◽

FARID SAAD

Keyword(s):

Type 2 Diabetes ◽

Real Life ◽

Registry Study ◽

Testosterone Therapy

Download Full-text

105 Improvement of Type 2 Diabetes (T2DM) in Hypogonadal Men receiving Long-term Testosterone Therapy: Real-life Evidence from a 10-registry Study in a Urological Office

Journal of Sexual Medicine ◽

10.1016/j.jsxm.2017.11.063 ◽

2018 ◽

Vol 15 (2) ◽

pp. S21-S22

Author(s):

F. Saad ◽

K. Haider ◽

A. Haider

Keyword(s):

Type 2 Diabetes ◽

Real Life ◽

Registry Study ◽

Testosterone Therapy

Download Full-text

Men with testosterone deficiency and a history of cardiovascular diseases benefit from long-term testosterone therapy: observational, real-life data from a registry study

Vascular Health and Risk Management ◽

10.2147/vhrm.s108947 ◽

2016 ◽

pp. 251 ◽

Cited By ~ 2

Author(s):

Farid Saad ◽

Karim Sultan Haider ◽

Aksam Yassin ◽

Gheorghe Doros ◽

Giuseppe Rosano ◽

...

Keyword(s):

Cardiovascular Diseases ◽

Real Life ◽

Testosterone Deficiency ◽

Registry Study ◽

Testosterone Therapy ◽

Life Data ◽

Real Life Data ◽

History Of

Download Full-text

097 In obese hypogonadal men, long-term testosterone therapy improves erectile function, quality of life and body weight – real-life evidence from a registry study

Journal of Sexual Medicine ◽

10.1016/j.jsxm.2018.04.100 ◽

2018 ◽

Vol 15 (7) ◽

pp. S168-S169

Author(s):

F. Saad ◽

A. Haider ◽

K.S. Haider ◽

G. Doros ◽

A. Traish

Keyword(s):

Quality Of Life ◽

Body Weight ◽

Erectile Function ◽

Real Life ◽

Registry Study ◽

Testosterone Therapy

Download Full-text

Remission of Type 2 Diabetes in 12% (16 of 133) Hypogonadal Men Receiving Long-Term Testosterone Therapy in a Real-Life Registry Study

Diabetes ◽

10.2337/db18-125-or ◽

2018 ◽

Vol 67 (Supplement 1) ◽

pp. 125-OR

Author(s):

AHMAD HAIDER ◽

KARIM S. HAIDER ◽

FARID SAAD

Keyword(s):

Type 2 Diabetes ◽

Real Life ◽

Registry Study ◽

Testosterone Therapy

Download Full-text

375 Remission of Type 2 Diabetes (T2DM) in 33.6% (51 of 152) Hypogonadal Men Receiving Long-term Testosterone Therapy for up to 12 Years in a Real-life Registry Study

Journal of Sexual Medicine ◽

10.1016/j.jsxm.2019.11.220 ◽

2020 ◽

Vol 17 (1) ◽

pp. S104

Author(s):

K.S. Haider ◽

A. Haider

Keyword(s):

Type 2 Diabetes ◽

Real Life ◽

Registry Study ◽

Testosterone Therapy

Download Full-text

PD45-04 INCIDENCE OF PROSTATE CANCER AND EFFECTS ON PROSTATE-RELATED PARAMETERS UNDER LONG-TERM THERAPY WITH TESTOSTERONE UNDECANOATE INJECTIONS (TU) IN HYPOGONADAL MEN FOR UP TO 84 MONTHS: REAL-LIFE EXPERIENCE FROM AN OBSERVATIONAL REGISTRY STUDY

The Journal of Urology ◽

10.1016/j.juro.2015.02.2576 ◽

2015 ◽

Vol 193 (4S) ◽

Author(s):

Ahmad Haider ◽

Karim Sultan Haider ◽

Gheorghe Doros ◽

Abdulmaged Traish

Keyword(s):

Prostate Cancer ◽

Life Experience ◽

Real Life ◽

Term Therapy ◽

Registry Study ◽

Testosterone Undecanoate ◽

Long Term Therapy

Download Full-text

Abstract #512: Is Long-Term Testosterone Therapy Effective in Secondary Prevention of Major Adverse Cardiovascular Events (MACE) in Hypogonadal Men with a History of Cardiovascular Disease (CVD)? Real-Life Data from a Registry Study

Endocrine Practice ◽

10.1016/s1530-891x(20)45070-0 ◽

2016 ◽

Vol 22 ◽

pp. 122

Author(s):

Farid Saad ◽

Ahmad Haider ◽

Karim Haider ◽

Gheorghe Doros ◽

Abdulmaged Traish

Keyword(s):

Cardiovascular Disease ◽

Cardiovascular Events ◽

Real Life ◽

Major Adverse Cardiovascular Events ◽

Registry Study ◽

Testosterone Therapy ◽

Life Data ◽

Real Life Data ◽

History Of

Download Full-text

Abstract #601 Mortality; Major Adverse Cardiovascular Events (Mace) and Weight are Reduced in 400 Hypogonadal Men on Long-Term Testosterone Therapy (TTH) Compared to 376 Untreated Hypogonadal Controls: Real-Life Data from A 10-Year Registry

Endocrine Practice ◽

10.1016/s1530-891x(20)47240-4 ◽

2018 ◽

Vol 24 ◽

pp. 143

Author(s):

Farid Saad ◽

Ahmad Haider ◽

Karim Haider ◽

Gheorghe Doros ◽

Abdulmaged Traish

Keyword(s):

Cardiovascular Events ◽

Real Life ◽

Major Adverse Cardiovascular Events ◽

Testosterone Therapy ◽

Life Data ◽

Real Life Data

Download Full-text